WEE1 and cancer: Patients with higher Wee1 expression (> 50% of cancer cells) had a better overall survival (median OS: not reached for Wee1‐high group vs. 37.2 months for Wee1‐low patients, P = 0.038) (Supporting Information Fig. S7A).